Anti-Rabies Serum Market Developments Shaping Growth Across The Forecast Period

The Business Research Company’s 2026 market reports feature enhanced tools like market attractiveness analysis, TAM assessment, and company scoring matrices, along with interactive dashboards, deeper supply chain insights, and startup coverage strengthening the depth, usability, and strategic value of insights.

How Is The Market Size Of The Anti-Rabies Serum Market Expected To Scale Between 2026 And 2030?

The anti-rabies serum market size has demonstrated significant expansion over recent years. It is anticipated to expand from $1.5 billion in 2025 to $1.58 billion in 2026, progressing at a compound annual growth rate (CAGR) of 5.6%. This historical growth can be linked to the increasing incidence of rabies exposure cases, the expansion of hospital-based emergency treatment protocols, the availability of equine-derived immunoglobulins, government-supported rabies control programs, and a growing awareness of post-exposure prophylaxis.

The anti-rabies serum market is projected for substantial expansion over the coming years. It is anticipated to reach a size of $1.95 billion by 2030, exhibiting a compound annual growth rate (CAGR) of 5.3%. This anticipated growth during the forecast period is fueled by factors such as the rising uptake of human anti-rabies immunoglobulin, broader implementation of rabies prevention programs in developing areas, increased capital injection into biologics production, a heightened emphasis on more secure serum options, and robust public health vaccination structures. Key trends characterizing this period are the greater adoption of human-sourced immunoglobulins, an increasing demand for prefilled syringe designs, the spread of cold-chain optimized serum delivery systems, an intensified focus on high-purity antibody compositions, and enhanced standardization of post-exposure prophylaxis guidelines.

Access Your Free Sample Report For In-Depth Market Analysis:

https://www.thebusinessresearchcompany.com/sample.aspx?id=20468&type=smp

Which Drivers Are Supporting The Anti-Rabies Serum Market Growth?

The growing occurrence of dog bites is projected to drive the expansion of the anti-rabies serum market moving forward. Dog bites are defined as injuries, ranging from minor to severe, sustained when a dog bites or scratches a person. These injuries can result in infections, serious wounds, and, in some instances, the transmission of diseases like rabies. Effective prevention and timely medical intervention are vital for managing and mitigating the risks associated with dog bites. Several factors contribute to the increased prevalence of dog bites, including heightened urbanization leading to more frequent interactions between humans and canines, a greater number of unrestrained or inadequately trained dogs, and insufficient public awareness or education about dog behavior and bite prevention. This surge in dog bite prevalence has consequently boosted the demand for anti-rabies serum, as its prompt administration is crucial for preventing rabies onset in individuals exposed to potentially infected animals. For example, in 2023, the American Veterinary Medical Association, a US-based non-profit organization, reported that the average cost for dog bite insurance claims was $58,545. Insurers paid out $1.12B in liability claims related to dog bites and other dog-related injuries during 2023. Dog bite claims saw an increase of nearly 10% in 2023. Therefore, the increasing prevalence of dog bites is a key factor propelling the growth of the anti-rabies serum market.

What Are The Different Segment Types In The Anti-Rabies Serum Market Segment Breakdown?

The anti-rabies serum market covered in this report is segmented –

1) By Type: Human Anti-rabies Immunoglobulin, Equine Anti-rabies Immunoglobulin

2) By Dosage And Form: Vials, Prefilled Syringes

3) By Route of Administration: Intravenous, Intramuscular

4) By End User: Hospitals, Clinics, Veterinary Hospitals

Subsegments:

1) By Human Anti-Rabies Immunoglobulin: Monovalent Human Anti-Rabies Immunoglobulin, Polyvalent Human Anti-Rabies Immunoglobulin, Intramuscular Human Anti-Rabies Immunoglobulin, Intravenous Human Anti-Rabies Immunoglobulin, Freeze-Dried Human Anti-Rabies Immunoglobulin

2) By Equine Anti-Rabies Immunoglobulin: Freeze-Dried Equine Anti-Rabies Immunoglobulin, Liquid Equine Anti-Rabies Immunoglobulin, Monovalent Equine Anti-Rabies Immunoglobulin, Polyvalent Equine Anti-Rabies Immunoglobulin

What Trends Are Influencing The Evolution Of The Anti-Rabies Serum Market?

Leading firms within the anti-rabies serum market are engaging in strategic collaborations to improve product innovation and broaden their market presence. These partnerships involve businesses utilizing one another’s capabilities and assets to attain shared advantages and favorable outcomes. As an example, in July 2023, Kedrion S.p.A., a US-based biopharmaceutical entity, formed an alliance with Kamada, an Israel-based biopharmaceutical company, for the distribution of KEDRAB (Rabies Immune Globulin [Human]) across the US. This joint effort has played a crucial role in the co-development and licensing of the product within the U.S., concurrently elevating public understanding of the disease. Due to their combined initiatives, the alliance has contributed to safeguarding people exposed to bites from rabid animals against severe and potentially fatal ailments.

Who Are The Well-Known Companies In The Anti-Rabies Serum Market?

Major companies operating in the anti-rabies serum market are Merck & Co Inc., Sanofi SA, GlaxoSmithKline PLC, Takeda Pharmaceutical Company Limited, HCX Pharmaceuticals LLP, Intas Pharmaceuticals Ltd, Bavarian Nordic AS, Serum Institute of India Pvt Ltd., Bharat Serums And Vaccines Limited, Indian Immunologicals Ltd., Bharat Biotech., National Institute of Health Islamabad, ViNS Bioproducts Ltd., Shanghai Serum Bio-technology, Premium Serums and Vaccines Pvt Ltd., Congruent Pharmachem, Haffkine Bio Pharmaceutical Corporation Limited, LEXICARE PHARMA PVT. LTD., Avin Darou, Central Research Institute Kasauli, Vigilomed Pharmaceuticals

Get The Full Anti-Rabies Serum Market Report:

https://www.thebusinessresearchcompany.com/report/anti-rabies-serum-global-market-report

Which Region Holds The Highest Market Share In The Anti-Rabies Serum Market?

North America was the largest region in the anti-rabies serum market in 2025. The regions covered in the anti-rabies serum market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request A Customized Anti-Rabies Serum Market Report For Competitive Insights:

https://www.thebusinessresearchcompany.com/report/anti-rabies-serum-global-market-report

Browse Through More Reports Similar to the Global Anti-Rabies Serum Market 2026, By The Business Research Company

Rabies Diagnostics Market Report 2026

https://www.thebusinessresearchcompany.com/report/rabies-diagnostics-global-market-report

Animal Therapeutics And Diagnostics Market Report 2026

https://www.thebusinessresearchcompany.com/report/animal-therapeutics-and-diagnostics-global-market-report

Anti Inflammatory Therapeutics Market Report 2026

https://www.thebusinessresearchcompany.com/report/anti-inflammatory-therapeutics-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795